How We Got Where We Are in Blood Pressure Targets
Johann Herberth(Medical University of South Carolina), Jan Basile(Medical University of South Carolina), Karim Soliman(Medical University of South Carolina), Tibor Fülöp(Medical University of South Carolina)
Cited by 17
Related Papers
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
|The Lancet|2019|3.1k
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
|The Lancet|2019|640
A Critical Review of Medication Adherence in Hypertension: Barriers and Facilitators Clinicians Should Consider
|Patient Preference and Adherence|2022|156
Novel loci associated with usual sleep duration: the CHARGE Consortium Genome-Wide Association Study
|Molecular Psychiatry|2014|129